Last reviewed · How we verify
Experimental: RAL QD — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Experimental: RAL QD (Experimental: RAL QD) — Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Experimental: RAL QD TARGET | Experimental: RAL QD | Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Experimental: RAL QD CI watch — RSS
- Experimental: RAL QD CI watch — Atom
- Experimental: RAL QD CI watch — JSON
- Experimental: RAL QD alone — RSS
Cite this brief
Drug Landscape (2026). Experimental: RAL QD — Competitive Intelligence Brief. https://druglandscape.com/ci/experimental-ral-qd. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab